​

Viking Therapeutics Ownership | Who Owns Viking Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Viking Therapeutics Ownership Summary

Viking Therapeutics is owned by 74.44% institutional investors, 5.96% insiders, and 19.60% retail investors. Fmr is the largest institutional shareholder, holding 15.99% of VKTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockViking Therapeutics74.44%5.96%19.60%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.54M15.99%$876.80M
Vanguard group10.10M9.76%$535.26M
Blackrock6.03M5.82%$319.45M
State street5.12M4.95%$271.54M
Jpmorgan chase2.25M2.18%$119.36M
Geode capital management1.86M1.80%$98.58M
Susquehanna group, llp1.40M1.36%$74.46M
Pictet asset management sa1.38M1.34%$73.23M
Viking global investors lp1.35M1.31%$71.80M
Alliancebernstein1.24M1.20%$65.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Artia global partners lp452.98K4.64%$24.01M
Nationale-nederlanden powszechne towarzystwo emerytalne520.08K4.48%$27.57M
Sassicaia capital advisers19.50K4.18%$1.03M
Apis capital advisors100.00K3.91%$5.30M
Profit investment management100.22K3.33%$5.31M
5am venture management237.56K2.82%$12.59M
Altium capital management lp122.00K2.64%$6.47M
Boone capital management174.77K2.42%$9.26M
Dafna capital management189.12K2.40%$10.03M
Braidwell lp1.11M1.84%$58.68M

Top Buyers

HolderShares% AssetsChange
Vanguard group10.10M0.01%2.31M
State street5.12M0.01%1.80M
Jpmorgan chase2.25M0.01%1.21M
Susquehanna group, llp1.40M0.01%1.12M
Toms capital investment management lp763.60K1.52%763.60K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---3.59M
Blackrock6.03M0.01%-2.25M
Rokos capital management llp---797.90K
Caption management---612.50K
American century companies273.45K0.01%-558.68K

New Positions

HolderShares% AssetsChangeValue
Toms capital investment management lp763.60K1.52%763.60K$40.48M
Norges bank182.37K0.00%182.37K$9.67M
Renaissance159.40K0.01%159.40K$8.45M
Discovery capital management, llc / ct146.90K1.00%146.90K$7.79M
Melqart asset management (uk)114.95K0.50%114.95K$6.09M

Sold Out

HolderChange
Scarborough advisors-10.00
Main street group-10.00
Institutional & family asset management-14.00
Parallax volatility advisers-16.00
Innealta capital-28.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20244606.48%82,562,3852.80%741.41%2728.80%106-4.50%
Jun 30, 20244280.71%80,251,5740.48%771.08%247-12.72%11124.72%
Mar 31, 202442593.18%79,870,2574.63%841.29%283154.96%8971.15%
Dec 31, 20232208.91%76,339,364-1.05%801.33%11114.43%521.96%
Sep 30, 2023202-8.60%77,149,9333.15%770.86%97-17.09%51-3.77%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S5.14M4.61%31.99K
Fidelity Growth Compy Commingled Pl O5.10M4.61%70.32K
Fidelity Growth Company Fund3.78M3.40%47.87K
Vanguard Total Stock Mkt Idx Inv3.31M2.97%-12.72K
SPDR® S&P Biotech ETF2.80M2.51%30.95K
Vanguard Small Cap Index2.64M2.37%5.15K
Vanguard Institutional Extnd Mkt Idx Tr1.65M1.48%-10.62K
Vanguard Small Cap Growth Index Inv1.45M1.30%-1.71K
Fidelity Growth Company K61.38M1.24%-6.22K
Fidelity Series Growth Company1.17M1.05%1.50K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 08, 2024MACARTNEY LAWSON-Sell$137.33K
Oct 28, 2024ZANTE GREG Chief Financial OfficerSell$3.70M
Oct 28, 2024ZANTE GREG Chief Financial OfficerSell$1.41M
Oct 28, 2024ZANTE GREG Chief Financial OfficerSell$712.80K
Oct 28, 2024ZANTE GREG Chief Financial OfficerSell$1.79M

Insider Transactions Trends

DateBuySell
2024 Q4-11
2024 Q3-25
2024 Q2-9
2024 Q1-12
2023 Q2-14

VKTX Ownership FAQ

Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 74.44%, followed by 5.96% insiders and 19.60% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 47.04%, which Viking Therapeutics exceeds.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Fmr (16.54M shares, 15.99%), Vanguard group (10.1M shares, 9.76%), and Blackrock (6.03M shares, 5.82%). Together, they hold 31.57% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Artia global partners lp is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.64% of its assets in 452.98K Viking Therapeutics shares, valued at 24.01M$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.14M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools